254 related articles for article (PubMed ID: 30763137)
1. Short- and long-term real-world effectiveness of omalizumab in severe allergic asthma: systematic review of 42 studies published 2008-2018.
MacDonald KM; Kavati A; Ortiz B; Alhossan A; Lee CS; Abraham I
Expert Rev Clin Immunol; 2019 May; 15(5):553-569. PubMed ID: 30763137
[TBL] [Abstract][Full Text] [Related]
2. 'Real-life' effectiveness studies of omalizumab in adult patients with severe allergic asthma: systematic review.
Abraham I; Alhossan A; Lee CS; Kutbi H; MacDonald K
Allergy; 2016 May; 71(5):593-610. PubMed ID: 26644231
[TBL] [Abstract][Full Text] [Related]
3. Omalizumab and long-term quality of life outcomes in patients with moderate-to-severe allergic asthma: a systematic review.
Colombo GL; Di Matteo S; Martinotti C; Oselin M; Valentino MC; Bruno GM; Pitotti C; Menzella F
Ther Adv Respir Dis; 2019; 13():1753466619841350. PubMed ID: 31035904
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of omalizumab in children and adolescents with moderate-to-severe asthma: A systematic literature review.
Corren J; Kavati A; Ortiz B; Colby JA; Ruiz K; Maiese BA; Cadarette SM; Panettieri RA
Allergy Asthma Proc; 2017 Jul; 38(4):250-263. PubMed ID: 28631599
[TBL] [Abstract][Full Text] [Related]
5. The Long-Term Effectiveness and Safety of Omalizumab on Patient- and Physician-Reported Asthma Control: A Three-Year, Real-Life Observational Study.
Schreiber J; Schwab Sauerbeck I; Mailänder C
Adv Ther; 2020 Jan; 37(1):353-363. PubMed ID: 31741282
[TBL] [Abstract][Full Text] [Related]
6. Longterm clinical outcomes of omalizumab therapy in severe allergic asthma: Study of efficacy and safety.
Mansur AH; Srivastava S; Mitchell V; Sullivan J; Kasujee I
Respir Med; 2017 Mar; 124():36-43. PubMed ID: 28284319
[TBL] [Abstract][Full Text] [Related]
7. Long-term evaluation of response to omalizumab therapy in real life by a novel multimodular approach: The Real-life Effectiveness of Omalizumab Therapy (REALITY) study.
Singh H; Peters JI; Kaur Y; Maselli DJ; Diaz JD
Ann Allergy Asthma Immunol; 2019 Nov; 123(5):476-482.e1. PubMed ID: 31382020
[TBL] [Abstract][Full Text] [Related]
8. "Real-life" Effectiveness Studies of Omalizumab in Adult Patients with Severe Allergic Asthma: Meta-analysis.
Alhossan A; Lee CS; MacDonald K; Abraham I
J Allergy Clin Immunol Pract; 2017; 5(5):1362-1370.e2. PubMed ID: 28351783
[TBL] [Abstract][Full Text] [Related]
9. Real-world effectiveness of omalizumab for severe allergic asthma treatment in Colombia.
Torres-Duque CA; Ocampo-Gómez J; Castillo MM; Cano-Rosales D; Giraldo-Montoya Á; Rodríguez F; Palacios-Ortega I; Durán-Silva M; Reynales H; García E;
BMC Pulm Med; 2022 Nov; 22(1):447. PubMed ID: 36437461
[TBL] [Abstract][Full Text] [Related]
10. The real world effect of omalizumab add on therapy for patients with moderate to severe allergic asthma: The ASTERIX Observational study.
Bhutani M; Yang WH; Hébert J; de Takacsy F; Stril JL
PLoS One; 2017; 12(8):e0183869. PubMed ID: 28859150
[TBL] [Abstract][Full Text] [Related]
11. Real-world safety and efficacy of omalizumab in patients with severe allergic asthma: A long-term post-marketing study in Japan.
Adachi M; Kozawa M; Yoshisue H; Lee Milligan K; Nagasaki M; Sasajima T; Miyamoto T; Ohta K
Respir Med; 2018 Aug; 141():56-63. PubMed ID: 30053973
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of Omalizumab in Severe Allergic Asthma and Nasal Polyposis: A Real-Life Study.
Tiotiu A; Oster JP; Roux PR; Nguyen Thi PL; Peiffer G; Bonniaud P; Dalphin JC; de Blay F
J Investig Allergol Clin Immunol; 2020; 30(1):49-57. PubMed ID: 30931917
[TBL] [Abstract][Full Text] [Related]
13. Omalizumab lowers asthma exacerbations, oral corticosteroid intake and blood eosinophils: Results of a 5-YEAR single-centre observational study.
Pelaia C; Calabrese C; Barbuto S; Busceti MT; Preianò M; Gallelli L; Savino R; Vatrella A; Pelaia G
Pulm Pharmacol Ther; 2019 Feb; 54():25-30. PubMed ID: 30414440
[TBL] [Abstract][Full Text] [Related]
14. Assessment of long-term omalizumab treatment in patients with severe allergic asthma long-term omalizumab treatment in severe asthma.
Özgür ES; Özge C; Ïlvan A; Naycı SA
J Asthma; 2013 Aug; 50(6):687-94. PubMed ID: 23557459
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness of omalizumab add-on to standard-of-care therapy in patients with uncontrolled severe allergic asthma in a Brazilian healthcare setting.
Suzuki C; Lopes da Silva N; Kumar P; Pathak P; Ong SH
J Med Econ; 2017 Aug; 20(8):832-839. PubMed ID: 28532191
[TBL] [Abstract][Full Text] [Related]
16. Omalizumab, the first available antibody for biological treatment of severe asthma: more than a decade of real-life effectiveness.
Pelaia C; Calabrese C; Terracciano R; de Blasio F; Vatrella A; Pelaia G
Ther Adv Respir Dis; 2018; 12():1753466618810192. PubMed ID: 30400762
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of omalizumab on patient reported outcomes, lung function, and inflammatory markers in severe allergic asthma.
Frix AN; Schleich F; Paulus V; Guissard F; Henket M; Louis R
Biochem Pharmacol; 2020 Sep; 179():113944. PubMed ID: 32240649
[TBL] [Abstract][Full Text] [Related]
18. Real-World Effectiveness of Omalizumab in Severe Allergic Asthma: A Meta-Analysis of Observational Studies.
Bousquet J; Humbert M; Gibson PG; Kostikas K; Jaumont X; Pfister P; Nissen F
J Allergy Clin Immunol Pract; 2021 Jul; 9(7):2702-2714. PubMed ID: 33486142
[TBL] [Abstract][Full Text] [Related]
19. Efficacy and effectiveness of omalizumab in the treatment of childhood asthma.
Tortajada-Girbés M; Bousquet R; Bosque M; Carrera Martínez JJ; Ibáñez MD; Moreira A; Nieto A; Plaza AM; Rivas C; Requena G; Sánchez-Solis M; Tabar A; Torres-Borrego J; Zapatero L
Expert Rev Respir Med; 2018 Sep; 12(9):745-754. PubMed ID: 30141696
[TBL] [Abstract][Full Text] [Related]
20. Long-term efficacy and safety of omalizumab in patients with persistent uncontrolled allergic asthma: a systematic review and meta-analysis.
Lai T; Wang S; Xu Z; Zhang C; Zhao Y; Hu Y; Cao C; Ying S; Chen Z; Li W; Wu B; Shen H
Sci Rep; 2015 Feb; 5():8191. PubMed ID: 25645133
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
